Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
1.
Scand J Urol ; 53(4): 240-245, 2019 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-31156002

RESUMEN

Background: Transurethral resection of the prostate (TURP) is considered the reference surgical method of treating benign prostatic enlargement (BPE) causing obstruction. The procedure still carries a significant risk of perioperative morbidity according to previous reports. The aim of the present study was to disclose complications after TURP undertaken in routine clinical practice at a non-academic center.Methods: All patients with BPE submitted to TURP from January 2010 to December 2012 were evaluated for complications occurring during hospital stay, after discharge up to the end of the third post-operative month and finally for any late endourological re-interventions undertaken up to five years after TURP. All complications were graded according to the Clavien-Dindo system.Results: In total, 354 men underwent a TURP during the study period. In total, 47% had pre-operative urinary retention. Significant co-morbidity was seen in 17% of men (ASA III-IV). Spinal anaesthesia was applied to 312 men (88%). During hospital stay, major complications, graded as Clavien-Dindo ≥ III, was seen in only eight men (2.3%). Minor complications occurred in 91 men (26%). Between hospital discharge and follow-up visit major complications were noted in 12 men (3.4%). Minor complications occurred in 79 men (22%). The only factor that was associated with an increased risk of a major complication was general anaesthesia. Late complications, requiring an endourological re-intervention, occurred in 30 men (9.7%).Conclusion: TUR-P in routine clinical practice was associated with a low incidence of severe complications. TUR syndrome was very rare. Within five years a small proportion of men require the transurethral intervention to be redone.


Asunto(s)
Hiponatremia/epidemiología , Complicaciones Posoperatorias/epidemiología , Hiperplasia Prostática/cirugía , Resección Transuretral de la Próstata/métodos , Obstrucción Uretral/cirugía , Retención Urinaria/epidemiología , Infecciones Urinarias/epidemiología , Anciano , Anestesia General/estadística & datos numéricos , Anestesia Raquidea/estadística & datos numéricos , Antibacterianos/uso terapéutico , Humanos , Hiponatremia/etiología , Incidencia , Masculino , Persona de Mediana Edad , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/fisiopatología , Hemorragia Posoperatoria/epidemiología , Hiperplasia Prostática/complicaciones , Reoperación , Índice de Severidad de la Enfermedad , Resección Transuretral de la Próstata/efectos adversos , Obstrucción Uretral/etiología , Infecciones Urinarias/tratamiento farmacológico
2.
Scand J Urol ; 52(5-6): 437-444, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-30681023

RESUMEN

BACKGROUND: Transurethral resection of the prostate (TURP) is the reference standard surgical treatment for lower urinary tract symptoms (LUTS) related to benign prostatic enlargement. The aim of this study was to investigate the response rate following TURP in two distinctly different patient categories; men with bothersome LUTS and men in urinary retention (UR) requiring catheterisation. METHODS: In total, 355 men underwent TURP due to LUTS or UR. Responders in the LUTS group were defined as having an International Prostate Symptom Score ≤7 or >50% loss compared to baseline, a Qmax ≥ 15 mL/s or >50% gain compared to baseline, a post-void residual ≤100 mL or a bother score ≤2. Patients fulfilling at least one out of the four criteria were defined as responders. In the UR group, responders were defined as being catheter-free at follow-up. RESULTS: In total, 337 men remained for final analysis. The proportion operated on due to UR was 46%. In men with LUTS, the response rate was 95%. One in four were classified as excellent responders, fulfilling all four outcome criteria. Men with UR had a successful removal of the catheter after TURP prior to discharge in 77% of the cases and an additional 6% within 3 months, yielding a total response rate of 83%. CONCLUSION: TURP is a successful procedure in men with bothersome LUTS and in men with UR. Considering the difference regarding voiding outcomes in men operated on due to LUTS or UR, these groups should be analysed separately in future studies comparing TURP against newer treatment modalities.


Asunto(s)
Síntomas del Sistema Urinario Inferior/cirugía , Hiperplasia Prostática/cirugía , Resección Transuretral de la Próstata , Retención Urinaria/cirugía , Anciano , Humanos , Tiempo de Internación , Modelos Logísticos , Síntomas del Sistema Urinario Inferior/etiología , Masculino , Persona de Mediana Edad , Análisis Multivariante , Hiperplasia Prostática/complicaciones , Insuficiencia del Tratamiento , Resultado del Tratamiento , Cateterismo Urinario , Retención Urinaria/etiología
3.
J Perianesth Nurs ; 28(6): 361-7, 2013 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-24267624

RESUMEN

BACKGROUND: Perioperative procedures in children can impair their emotional status negatively with stress and/or anxiety. Cortisol concentrations and drawings could be helpful in gaining information about a child's levels of stress and/or anxiety when attending the hospital for surgery. PURPOSE: The purpose of this study was to determine the degree of anxiety and stress as well as to explore the association between objective measures of stress (cortisol concentration in saliva) and subjective assessment of hospital anxiety (children's drawings) as interpreted by the Swedish version of the Child Drawing: Hospital manual. METHODS: A total of 93 children scheduled for day surgery were included. Salivary cortisol was sampled preoperatively on the day of surgery at which time the children were also requested to make a drawing of a person at the hospital. RESULTS: Results showed no association between salivary cortisol concentration and the CD:H score. CONCLUSION: The drawings and salivary cortisol concentration preoperatively on the day of surgery reflect different components of the conditions of fear, anxiety, or stress emerging in the situation.


Asunto(s)
Procedimientos Quirúrgicos Ambulatorios , Arteterapia , Hidrocortisona/análisis , Saliva/química , Ansiedad/diagnóstico , Niño , Humanos , Cuidados Preoperatorios , Estrés Psicológico/diagnóstico
4.
Scand J Urol Nephrol ; 41(6): 516-20, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17853027

RESUMEN

OBJECTIVES: To evaluate how age and the duration of the condition influence the distress caused by the chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) and to study how heat and cold influence the symptoms associated with CP/ CPPS as reported by patients afflicted with the condition. MATERIAL AND METHODS: Forty-eight men (median age 50 years; age range 27-70 years) who had suffered from CP/CPPS for a duration ranging from 18 months to 40 years were included in the study. The evaluation included determination of the serum prostate-specific antigen level, the National Institutes of Health's Chronic Prostatitis Symptom Index (NIH-CPSI) and the International Prostate Symptom Score (IPSS). RESULTS: The mean NIH-CPSI score was 23.0 +/- 4.8. The mean IPSS was 14.3 +/- 7.2. Dysuria was reported by 30 men (63%) and ejaculatory pain by 22 (48%). Men with dysuria had painful ejaculations more often (60%) than men without (22%) (p <0.01). There was a strong negative correlation between age and the NIH-CPSI quality of life (QOL) score (correlation coefficient 0.646; p < 0.001). Independent of age, the duration of the disease also correlated with the NIH-CPSI QOL score (correlation coefficient -0.48; p < 0.02). The total NIH-CPSI score did not correlate with either age or the duration of the disease. Nearly every other man stated that the disease had started in association with a specific event, which for 15 men (31%) included exposure to cold. Forty men (83%) reported that cold caused symptom aggravation and/or induced a relapse. Thirty men (63%) stated that taking a hot bath and 22 (46%) reported that spending time in a hot climate decreased the symptoms. CONCLUSIONS: Age, as well as the duration of the condition, influenced the distress induced by CP/CPPS, suggesting an improved coping ability with time as well as age. The ambient temperature appears to play a role as cold was frequently reported as causing symptom aggravation and heat was often reported to be ameliorating. The mechanisms behind this association between CP/CPPS and temperature as well as the correlation between ejaculatory pain and dysuria require further study.


Asunto(s)
Frío/efectos adversos , Dolor Pélvico/etiología , Dolor Pélvico/fisiopatología , Prostatitis/etiología , Prostatitis/fisiopatología , Adulto , Factores de Edad , Anciano , Baños , Enfermedad Crónica , Climatoterapia , Estudios Transversales , Disuria/etiología , Disuria/fisiopatología , Disuria/terapia , Eyaculación/fisiología , Encuestas Epidemiológicas , Humanos , Masculino , Persona de Mediana Edad , Análisis Multivariante , Dimensión del Dolor , Dolor Pélvico/terapia , Próstata/irrigación sanguínea , Prostatitis/terapia , Calidad de Vida , Factores de Tiempo , Vasoconstricción/fisiología
5.
Scand J Urol Nephrol ; 40(1): 26-30, 2006.
Artículo en Inglés | MEDLINE | ID: mdl-16452052

RESUMEN

OBJECTIVE: To investigate the relevance of bladder tumour screening using haematuria dipsticks and a bladder tumour marker in a random selection of men, age 60-70 years, from a well-defined geographical area using both fluorescence and white-light cystoscopy. MATERIAL AND METHODS: A total of 2000 randomly selected men, age 60-70 years, were invited by mail to participate in a screening for bladder tumours by having their urine tested with a dipstick for haematuria and a bladder tumour marker (UBC). Men with 5-10 red blood cells (RBC)/microl and an International Prostate Symptom Score (IPSS) of >10 and all men with =25 RBC/microl and/or elevated UBC levels underwent both white-light and fluorescence cystoscopy. RESULTS: A total of 1096 men (55%) responded and were included in the study. The incidence of 5-10 RBC/microl was high: 14%. A tumour was detected in one of the 62 men with 5-10 RBC/microl and an IPSS of >10. Among the 10% of men (n=112) with =25 RBC/microl, four bladder tumours were detected. Another two tumours were detected in men without haematuria (positive UBC test). No tumours were observed using only fluorescence cystoscopy. CONCLUSIONS: Fluorescence cystoscopy and the UBC test were of no use in this screening situation. The incidence of haematuria (=5-10 RBC/microl) was so high (1:4) that this borderline for bladder tumour screening appears unrealistic. The incidence of =25 RBC/microl was 1:10 and one of 28 cystoscopies revealed a bladder tumour. All seven tumours were detected in men who were or had been smokers. A haematuria-based screening among older male smokers with =25 RBC/microl on dipstick testing is thus an option that should be considered.


Asunto(s)
Biomarcadores de Tumor/análisis , Cistoscopía/métodos , Hematuria/diagnóstico , Tamizaje Masivo/métodos , Neoplasias de la Vejiga Urinaria/diagnóstico , Distribución por Edad , Anciano , Fluorescencia , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Probabilidad , Pronóstico , Tiras Reactivas , Medición de Riesgo , Sensibilidad y Especificidad , Suecia/epidemiología , Resección Transuretral de la Próstata/métodos , Neoplasias de la Vejiga Urinaria/epidemiología , Neoplasias de la Vejiga Urinaria/cirugía
6.
Scand J Urol Nephrol ; 36(5): 344-7, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-12487738

RESUMEN

OBJECTIVE: To evaluate the costs of bladder tumour treatment and follow-up. MATERIAL AND METHODS: The incidence of bladder tumours, both new and recurrences, and the cost of bladder tumour treatments with curative intent were registered during a 4-year period (1994-97). RESULTS: The incidence of new tumours varied from year to year, in contrast to the number of recurrent tumours, which remained remarkably stable. The total cost of bladder cancer diagnosis, treatment and follow-up was almost 7,000,000 SEK per year (2,800,000 SEK per 100,000 inhabitants per year). The number of therapeutic events per year remained stable at 256 +/- 17 (102 per 100,000 inhabitants per year). Cystectomies were responsible for 34% of the expenditure and transurethral procedures for 40%. Follow-up cystoscopies accounted for only 13% of the total cost. One-third of the routine follow-up cystoscopies resulted in a therapeutic procedure. The cost of transurethral resections and extirpations was approximately five times higher when performed with the patient hospitalized compared to when performed as day-care surgery. CONCLUSIONS: A reduction in the number of follow-up cystoscopies will only produce marginal economic savings. Further savings could be made if more transurethral resections and extirpations/fulgurations were performed on an outpatient basis. Another important goal is to reduce the median cost per cystectomy.


Asunto(s)
Costos de la Atención en Salud , Recurrencia Local de Neoplasia/economía , Recurrencia Local de Neoplasia/terapia , Neoplasias de la Vejiga Urinaria/economía , Neoplasias de la Vejiga Urinaria/terapia , Anciano , Anciano de 80 o más Años , Terapia Combinada/efectos adversos , Terapia Combinada/métodos , Costo de Enfermedad , Costos y Análisis de Costo , Cistectomía/economía , Cistectomía/métodos , Cistoscopía/economía , Cistoscopía/métodos , Femenino , Estudios de Seguimiento , Costos de Hospital , Humanos , Masculino , Persona de Mediana Edad , Recurrencia Local de Neoplasia/patología , Suecia , Resección Transuretral de la Próstata/economía , Resección Transuretral de la Próstata/métodos , Neoplasias de la Vejiga Urinaria/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA